Drug Trial Radar · NCT05571059
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
128
Planned (sponsor's estimate)
Start
Jan 31, 2024
Primary completion
Jan 2028
Study completion Jan 2028
Sponsor
- Lead sponsor
- Cumberland PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 7, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
Ifetroban SodiumDrug
Once daily oral ifetroban
PlaceboDrug
Matching oral placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Forced Vital Capacity (FVC) in mLTime frame: Baseline through 12 months
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Biosolutions Clinical Research
La Mesa, California · Active not recruiting
University of California San Francisco
San Francisco, California · Recruiting
UConn Health
Farmington, Connecticut · Recruiting
Mayo Clinic Jacksonville
Jacksonville, Florida · Recruiting
Miami VA Health System
Miami, Florida · Recruiting
Northwestern Medicine
Chicago, Illinois · Recruiting
Indiana University Health
Indianapolis, Indiana · Recruiting
University of Kansas
Kansas City, Kansas · Recruiting
University of Louisville
Louisville, Kentucky · Recruiting
Beaumont Hospital, Royal Oak
Royal Oak, Michigan · Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Recruiting
University of Rochester
Rochester, New York · Recruiting
UNC Chapel Hill
Chapel Hill, North Carolina · Recruiting
Bend Memorial Hospital
Bend, Oregon · Recruiting
Temple University Hospital
Philadelphia, Pennsylvania · Recruiting
Avera Research Institute
Sioux Falls, South Dakota · Recruiting
Pulmonary & Sleep Specialists
Dickson, Tennessee · Active not recruiting
Baylor University Medical Center
Dallas, Texas · Recruiting
Premier Pulmonary Critical Care and Sleep Medicine
Denison, Texas · Recruiting
UW Health University Hospital
Madison, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.